CIBC Bancorp USA’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$89.4M Buy
1,035,790
+8,521
+0.8% +$751K 0.11% 165
2026
Q2
$80.4M Buy
1,027,269
+164,012
+19% +$13.2M 0.1% 188
2026
Q1
$74.5M Buy
+863,257
New +$82.7M 0.1% 183
2025
Q3
$16.8M Buy
+176,768
New +$16.2M 0.09% 173

Other funds holding MDT

CIBC Bancorp USA's MDT Position: Q3 2026 in Review

CIBC Bancorp USA increased its Medtronic (MDT) stake by 0.83% in Q3 2026, buying an estimated $751K and bringing the position to 1,035,790 shares worth $89.4M. The position accounts for 0.11% of the portfolio, ranked #165.

CIBC Bancorp USA first reported a position in MDT in Q3 2025 and has held it in 4 quarters since. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • CIBC Bancorp USA held 1,035,790 shares of Medtronic worth $89.4M as of Q3 2026.
  • CIBC Bancorp USA bought 8,521 Medtronic shares in Q3 2026, an estimated $751K.
  • Medtronic made up 0.11% of CIBC Bancorp USA's portfolio in Q3 2026, its #165 holding.
  • CIBC Bancorp USA first reported a position in Medtronic in Q3 2025 and has held it in 4 quarters since.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.